Man in pharmacy looking at medicine bottle.
·
3 MIN READ

What’s at stake in this week’s CVS-Aetna merger hearing 

Unprecedented federal court hearing on $70 billion deal demonstrates AMA’s effectiveness in challenging the anticompetitive consolidation of certain health care markets.  

Access to Care
·
6 MIN READ

Dec. 13, 2018: National Advocacy Update

Choice and competition in health care, new drug pricing rule for Part D drugs and more in AMA's national advocacy news.

Advocacy Update
A shark swimming through the water
·
4 MIN READ

Most commercial health insurance markets are highly concentrated

Health insurance competition is sorely lacking, AMA research shows, and growing consolidation is not bringing lower premiums for patients.

Access to Care
·
4 MIN READ

Nov. 29, 2018: Advocacy spotlight on Majority of commercial health insurance markets are highly concentrated

Majority of commercial health insurance markets are highly concentrated; find out how AMA is answering the questions you have.

Advocacy Update
·
3 MIN READ

Competition levels drop for health insurance markets across 25 states

New AMA study finds half of all states had commercial health insurance markets that were less competitive in 2017 than the previous year.

Press Releases
·
14 MIN READ

AMA president outlines efforts to attack dysfunction in health care

Dr. McAneny also issues urgent calls for physician leadership to help reduce gun violence in America, end harassment in medicine

Press Releases
·
1 MIN READ

AMA statement on CVS-Aetna merger: not enough patient protection

AMA welcomes the DOJ requiring Aetna to divest its Medicare Part D business, but disappointed that they didn’t go further by blocking the CVS-Aetna merger.

Press Releases
·
4 MIN READ

Sept. 6, 2018: State Advocacy Update

Illinois enacts parity protections, Utah physicians oppose CVS-Aetna merger and more in AMA's latest state advocacy news.

Advocacy Update
·
3 MIN READ

Aug. 9, 2018: Advocacy spotlight on AMA urges DOJ to block CVS-Aetna merger

In a letter sent to the U.S. Department of Justice (DOJ), the AMA urged the DOJ to oppose to the CVS-Aetna merger. Learn about AMA's "concern that market concentration is a leading cause of high costs in health care."

Advocacy Update